Hoth Therapeutics Inc (HOTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,121 | 4,947 | 4,349 | 1,691 | 3,215 |
| Marketable Securities | 1,290 | 2,012 | 491 | 804 | 804 |
| Other current assets | 0 | 0 | 0 | 30 | 0 |
| TOTAL | $5,490 | $7,016 | $4,897 | $2,635 | $4,133 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 1 | 1 | 1 |
| Investments And Advances | 410 | 410 | 250 | 0 | 0 |
| Other Non-Current Assets | 50 | 0 | 200 | 200 | 200 |
| TOTAL | $460 | $410 | $451 | $201 | $201 |
| Total Assets | $5,950 | $7,426 | $5,348 | $2,836 | $4,335 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 23 | 180 | 515 | 404 | 18 |
| Accrued Expenses | 265 | 175 | 8 | 36 | 8 |
| TOTAL | $288 | $355 | $523 | $440 | $25 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 285 | 235 | 0 | 0 | 0 |
| TOTAL | $285 | $235 | $N/A | $N/A | $N/A |
| Total Liabilities | $573 | $590 | $523 | $440 | $25 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 537 | 537 | 464 | 405 | 405 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -18,657 | -16,540 | -14,042 | -12,216 | -8,304 |
| Other shareholders' equity | -3 | -1 | 0 | 0 | 0 |
| TOTAL | $5,377 | $6,836 | $4,824 | $2,396 | $4,309 |
| Total Liabilities And Equity | $5,950 | $7,426 | $5,348 | $2,836 | $4,335 |